Sleep Abnormalities in SLC13A5 Citrate Transporter Disorder
Genes · 2024
DOI: 10.3390/genes15101338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Raegan M Adams und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Alzheimer's and Neurodegenerative Diseases, UT Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Sleep Wake Disorders, Mice, Knockout. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Taysha Gene Therapies, TESS Research Foundation.
Abstract (Originalsprache)
Background
SLC13A5 Citrate Transporter Disorder is a rare pediatric neurodevelopmental disorder. Patients have epilepsy, developmental disability, and impaired mobility. While sleep disorders are common in children with neurodevelopmental disorders, sleep abnormalities have not been reported in SLC13A5 patients.
Methods
Here, we assessed sleep disturbances in patients through caregiver reported surveys and in a transgenic mouse model of SLC13A5 deficiency. A total of 26 patients were evaluated with the Sleep Disturbance Scale for Children three times over a one-year span. Sleep and wake activities were assessed in the SLC13A5 knock-out (KO) mice using wireless telemetry devices.
Results
A high burden of clinically significant sleep disturbances were reported in the patients, with heterogeneous symptoms that remained stable across time. While sleep disturbances were common, less than 30% of patients were prescribed medications for sleep. Comparatively, in SLC13A5 KO mice using EEG recordings, significant alterations were found during light cycles, when rodents typically sleep. During the sleep period, SLC13A5 mice had increased activity, decreased paradoxical sleep, and changes in absolute power spectral density, indicating altered sleep architecture in the mouse model.
Conclusions
Our results demonstrate a significant component of sleep disturbances in SLC13A5 patients and mice, highlighting a potential gap in patient care. Further investigation of sleep dysfunction and the underlying etiologies of sleep disturbances in SLC13A5 citrate transporter disorder is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Alzheimer's and Neurodegenerative Diseases, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA 94304, USA.
- Perot Neuroscience Translational Research Center, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02912, USA.
- Department of Psychiatry & Human Behavior, Brown University, Providence, RI 02912, USA.
ORCID-Profile: Raegan M Adams, Brian C Kavanaugh, Tanya L Brown, Kimberly Nye, Brenda E Porter, Kimberly Goodspeed, Rachel M Bailey
Förderung
- NIDDK NIH HHS
- Taysha Gene Therapies
- TESS Research Foundation
Zitieren
APA
Adams, R. M., Ozlu, C., Bailey, L. E., Solidum, R. M., Cooper, S., Best, C. R., Elacio, J., Kavanaugh, B. C., Brown, T. L., Nye, K., Liu, J., Porter, B. E., Goodspeed, K., & Bailey, R. M. (2024). Sleep Abnormalities in SLC13A5 Citrate Transporter Disorder. Genes. https://doi.org/10.3390/genes15101338
Vancouver
Adams RM, Ozlu C, Bailey LE, Solidum RM, Cooper S, Best CR, et al. Sleep Abnormalities in SLC13A5 Citrate Transporter Disorder. Genes. 2024. doi:10.3390/genes15101338
BibTeX
@article{Adams2024,
author = {Adams, Raegan M and Ozlu, Can and Bailey, Lauren E and Solidum, Rayann M and Cooper, Sydney and Best, Carrie R and Elacio, Jennifer and Kavanaugh, Brian C and Brown, Tanya L and Nye, Kimberly and Liu, Judy and Porter, Brenda E and Goodspeed, Kimberly and Bailey, Rachel M},
title = {Sleep Abnormalities in SLC13A5 Citrate Transporter Disorder},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15101338}
}
EUVIMED